Two of the 3 predictors in this patient population probably could not be modified—history of COPD and preoperative serum albumin levels—whereas the rate of intraoperative crystalloid administration is a readily adjustable predictor affecting outcomes in this patient population. This evidence concerns the gene ALB and chronic obstructive pulmonary disease.